MAP2
Microtubule-associated protein 2
Also known as: MAP2A, MAP2B, MAP2C, MTAP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11137
- Gene
- MAP2
- Ensembl
- ENSG00000078018
- Chromosome
- 2
- Canonical length
- 1827 aa
- Protein class
- FDA approved drug targets, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Primary cilium,Cytosol
OverviewNCBI Gene
This gene encodes a protein that belongs to the microtubule-associated protein family. The proteins of this family are thought to be involved in microtubule assembly, which is an essential step in neurogenesis. The products of similar genes in rat and mouse are neuron-specific cytoskeletal proteins that are enriched in dentrites, implicating a role in determining and stabilizing dentritic shape during neuron development. A number of alternatively spliced variants encoding distinct isoforms have been described. [provided by RefSeq, Jan 2010]
Canonical amino-acid sequenceUniProt
1827 residues, UniProt reviewed canonical sequence.
>P11137|MAP2
1 MADERKDEAK APHWTSAPLT EASAHSHPPE IKDQGGAGEG LVRSANGFPY REDEEGAFGE
61 HGSQGTYSNT KENGINGELT SADRETAEEV SARIVQVVTA EAVAVLKGEQ EKEAQHKDQT
121 AALPLAAEET ANLPPSPPPS PASEQTVTVE EDLLTASKME FHDQQELTPS TAEPSDQKEK
181 ESEKQSKPGE DLKHAALVSQ PETTKTYPDK KDMQGTEEEK APLALFGHTL VASLEDMKQK
241 TEPSLVVPGI DLPKEPPTPK EQKDWFIEMP TEAKKDEWGL VAPISPGPLT PMREKDVFDD
301 IPKWEGKQFD SPMPSPFQGG SFTLPLDVMK NEIVTETSPF APAFLQPDDK KSLQQTSGPA
361 TAKDSFKIEE PHEAKPDKMA EAPPSEAMTL PKDAHIPVVE EHVMGKVLEE EKEAINQETV
421 QQRDTFTPSG QEPILTEKET ELKLEEKTTI SDKEAVPKES KPPKPADEEI GIIQTSTEHT
481 FSEQKDQEPT TDMLKQDSFP VSLEQAVTDS AMTSKTLEKA MTEPSALIEK SSIQELFEMR
541 VDDKDKIEGV GAATSAELDM PFYEDKSGMS KYFETSALKE EATKSIEPGS DYYELSDTRE
601 SVHESIDTMS PMHKNGDKEF QTGKESQPSP PAQEAGYSTL AQSYPSDLPE EPSSPQERMF
661 TIDPKVYGEK RDLHSKNKDD LTLSRSLGLG GRSAIEQRSM SINLPMSCLD SIALGFNFGR
721 GHDLSPLASD ILTNTSGSMD EGDDYLPATT PALEKAPCFP VESKEEEQIE KVKATGEEST
781 QAEISCESPF LAKDFYKNGT VMAPDLPEML DLAGTRSRLA SVSADAEVAR RKSVPSETVV
841 EDSRTGLPPV TDENHVIVKT DSQLEDLGYC VFNKYTVPLP SPVQDSENLS GESGTFYEGT
901 DDKVRRDLAT DLSLIEVKLA AAGRVKDEFS VDKEASAHIS GDKSGLSKEF DQEKKANDRL
961 DTVLEKSEEH ADSKEHAKKT EEAGDEIETF GLGVTYEQAL AKDLSIPTDA SSEKAEKGLS
1021 SVPEIAEVEP SKKVEQGLDF AVQGQLDVKI SDFGQMASGL NIDDRRATEL KLEATQDMTP
1081 SSKAPQEADA FMGVESGHMK EGTKVSETEV KEKVAKPDLV HQEAVDKEES YESSGEHESL
1141 TMESLKADEG KKETSPESSL IQDEIAVKLS VEIPCPPAVS EADLATDERA DVQMEFIQGP
1201 KEESKETPDI SITPSDVAEP LHETIVSEPA EIQSEEEEIE AQGEYDKLLF RSDTLQITDL
1261 GVSGAREEFV ETCPSEHKGV IESVVTIEDD FITVVQTTTD EGESGSHSVR FAALEQPEVE
1321 RRPSPHDEEE FEVEEAAEAQ AEPKDGSPEA PASPEREEVA LSEYKTETYD DYKDETTIDD
1381 SIMDADSLWV DTQDDDRSIM TEQLETIPKE EKAEKEARRS SLEKHRKEKP FKTGRGRIST
1441 PERKVAKKEP STVSRDEVRR KKAVYKKAEL AKKTEVQAHS PSRKFILKPA IKYTRPTHLS
1501 CVKRKTTAAG GESALAPSVF KQAKDKVSDG VTKSPEKRSS LPRPSSILPP RRGVSGDRDE
1561 NSFSLNSSIS SSARRTTRSE PIRRAGKSGT STPTTPGSTA ITPGTPPSYS SRTPGTPGTP
1621 SYPRTPHTPG TPKSAILVPS EKKVAIIRTP PKSPATPKQL RLINQPLPDL KNVKSKIGST
1681 DNIKYQPKGG QVQIVTKKID LSHVTSKCGS LKNIRHRPGG GRVKIESVKL DFKEKAQAKV
1741 GSLDNAHHVP GGGNVKIDSQ KLNFREHAKA RVDHGAEIIT QSPGRSSVAS PRRLSNVSSS
1801 GSINLLESPQ LATLAEDVTA ALAKQGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 379 nTPM
Expression across tissuesHPA
Tissue
- retina: 379 nTPM
- cerebral cortex: 260 nTPM
- amygdala: 195 nTPM
- hypothalamus: 182 nTPM
- basal ganglia: 169 nTPM
- hippocampal formation: 145 nTPM
Single-cell type
- cone photoreceptor cells: 2,546 nCPM
- rod photoreceptor cells: 1,758 nCPM
- pituicytes/fscs: 1,295 nCPM
- oligodendrocyte progenitor cells: 1,122 nCPM
- brain inhibitory neurons: 971 nCPM
- other brain neurons: 936 nCPM
Immune cell
- naive B-cell: 0.8 nTPM
- memory B-cell: 0.7 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebral cortex: 798 nTPM
- hypothalamus: 749 nTPM
- hippocampal formation: 542 nTPM
- basal ganglia: 513 nTPM
- white matter: 462 nTPM
- pons: 460 nTPM
ReferencesPubMed · IEDB
Publications for MAP2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus.
2004 · Arthritis Rheum · RCR 1.4 · 59 citations - Antibodies to microtubule-associated protein-2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus.
2016 · Mod Rheumatol · RCR 0.8 · 18 citations - Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome.
2005 · J Autoimmune Dis · RCR 0.5 · 19 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.11
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- central nervous system neuron development
- dendrite development
- dendrite morphogenesis
- microtubule cytoskeleton organization
- negative regulation of axon extension
- negative regulation of microtubule polymerization
- neuron projection development
- positive regulation of anterograde dense core granule transport
- positive regulation of anterograde synaptic vesicle transport
- regulation of microtubule polymerization
- regulation of organelle transport along microtubule
- regulation of protein localization
Molecular functions
- calmodulin binding
- dystroglycan binding
- microtubule binding
- structural molecule activity
- tau protein binding
Cellular components
- axon hillock
- axon initial segment
- basal dendrite
- cilium
- cytoplasm
- cytosol
- dendrite
- dendrite cytoplasm
- dendritic branch
- dendritic filopodium
- dendritic growth cone
- dendritic shaft
- distal dendrite
- microtubule
- microtubule associated complex
- neuron projection
- neuronal cell body
- plasma membrane
- primary dendrite
- proximal dendrite
- proximal neuron projection
- apical distal dendrite
Protein domainsUniProt · Pfam · InterPro
- Microtubule associated protein, tubulin-binding repeat
- Microtubule associated protein MAP2/MAP4/Tau
- Tau and MAP protein, tubulin-binding repeat
- MAP2/Tau projection
- MAP2/Tau projection domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAP2 as an antibody target. Whether an autoantibody or antibody against MAP2 could matter depends on whether native MAP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...